{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:51:48Z","timestamp":1773093108320,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"USDA","doi-asserted-by":"publisher","award":["6040-32000-073-00D"],"award-info":[{"award-number":["6040-32000-073-00D"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014966","name":"ARS","doi-asserted-by":"publisher","award":["6040-32000-074-00D"],"award-info":[{"award-number":["6040-32000-074-00D"]}],"id":[{"id":"10.13039\/100014966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.074","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T09:20:22Z","timestamp":1572945622000},"page":"925-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic stability of a Newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0386-793X","authenticated-orcid":false,"given":"Qingzhong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-7199","authenticated-orcid":false,"given":"Kiril","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-4743","authenticated-orcid":false,"given":"Claudio L.","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Spatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Zsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.074_b0005","series-title":"Diseases of Poultry","first-page":"161","article-title":"Infectious laryngotracheitis","author":"Garcia","year":"2013"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.074_b0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/03079457.2013.800634","article-title":"Challenges and recent advancements in infectious laryngotracheitis virus vaccines","volume":"42","author":"Coppo","year":"2013","journal-title":"Avian Pathol"},{"key":"10.1016\/j.vaccine.2019.10.074_b0015","series-title":"Diseases of Poultry","first-page":"98","article-title":"Newcastle Disease","author":"Miller","year":"2013"},{"key":"10.1016\/j.vaccine.2019.10.074_b0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vetmic.2016.12.019","article-title":"Newcastle disease vaccines-A solved problem or a continuous challenge?","volume":"206","author":"Dimitrov","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.10.074_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2307\/1587792","article-title":"Strain stability and immunologic characterizatics of tissue-culture modified infectious laryngotracheitis virus","volume":"9","author":"Gelenczei","year":"1962","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2019.10.074_b0030","first-page":"54","article-title":"The devlopment of a vaccine against avian infectious laryngotracheitis. I. Modification of a laryngotracheitis virus","volume":"26","author":"Samberg","year":"1969","journal-title":"Refu Vet"},{"key":"10.1016\/j.vaccine.2019.10.074_b0035","doi-asserted-by":"crossref","DOI":"10.1080\/03079457.2014.886004","article-title":"Molecular epidemiology of infectious laryngotracheitis: a review","author":"Menendez","year":"2014","journal-title":"Avian Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.074_b0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0034-5288(18)31158-5","article-title":"Effects of certain stress factors on the re-excretion of infectious laryngotracheitis virus from latently infected carrier birds","volume":"46","author":"Hughes","year":"1989","journal-title":"Res Vet Sci"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2019.10.074_b0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01316755","article-title":"Latency and reactivation of infectious laryngotracheitis vaccine virus","volume":"121","author":"Hughes","year":"1991","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.074_b0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2307\/1591188","article-title":"Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage","volume":"35","author":"Guy","year":"1991","journal-title":"Avian Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.074_b0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2307\/1591340","article-title":"Virulence of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates","volume":"34","author":"Guy","year":"1990","journal-title":"Avian Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.074_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-1135(94)00115-D","article-title":"The effect of serial in vivo passage on the expression of virulence and DNA stability of an infectious laryngotracheitis virus strain of low virulence","volume":"45","author":"Kotiw","year":"1995","journal-title":"Vet Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.074_b0065","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.vaccine.2016.12.038","article-title":"Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies","volume":"35","author":"Yu","year":"2017","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2019.10.074_b0070","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1128\/JVI.01321-14","article-title":"Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges","volume":"88","author":"Zhao","year":"2014","journal-title":"J Virol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2019.10.074_b0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1099\/0022-1317-80-1-131","article-title":"Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae","volume":"80","author":"de Leeuw","year":"1999","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.074_b0080","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1128\/JVI.73.6.5001-5009.1999","article-title":"Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence","volume":"73","author":"Peeters","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.074_b0085","series-title":"The Biology of Paramyxoviruses","first-page":"69","article-title":"Newcastle disease and ralated avian paramyxoviruses","author":"Samal","year":"2011"},{"key":"10.1016\/j.vaccine.2019.10.074_b0090","series-title":"Fields Virology","first-page":"957","article-title":"Paramyxoviridae","author":"Lamb","year":"2013"},{"key":"10.1016\/j.vaccine.2019.10.074_b0095","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.virol.2015.03.018","article-title":"The RNA synthesis machinery of negative-stranded RNA viruses","volume":"479\u2013480","author":"Ortin","year":"2015","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.074_b0100","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1128\/jvi.69.4.2412-2419.1995","article-title":"Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication","volume":"69","author":"Yu","year":"1995","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.10.074_b0105","doi-asserted-by":"crossref","first-page":"e0162484","DOI":"10.1371\/journal.pone.0162484","article-title":"Presence of vaccine-derived newcastle disease viruses in wild birds","volume":"11","author":"Ayala","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.074_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2307\/1589696","article-title":"Historical note on the origin of the LaSota strain of Newcastle disease virus","volume":"24","author":"Goldhaft","year":"1980","journal-title":"Avian Dis"},{"key":"10.1016\/j.vaccine.2019.10.074_b0115","series-title":"Newcastle Disease","first-page":"318","article-title":"Control by vaccination","author":"Meulemans","year":"1988"},{"key":"10.1016\/j.vaccine.2019.10.074_b0120","doi-asserted-by":"crossref","first-page":"7278459","DOI":"10.1155\/2018\/7278459","article-title":"Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives","volume":"2018","author":"Bello","year":"2018","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.074_b0125","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/JVI.01801-15","article-title":"Evolution of newcastle disease virus quasispecies diversity and enhanced virulence after passage through chicken air sacs","volume":"90","author":"Meng","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.10.074_b0130","unstructured":"Alexander DJ. Newcastle Disease Virus and other Avian Paramyxoviruses. In: Swayne D, Glisson JR, Jackwood MW, Pearson JE, Reed WM, editors. A laboratory manual for the isolation and identification of avian pathogens. 4th Edition ed. Kennett Square, PA: American Association of Avian Pathologists; 1998, p. 156-63."},{"issue":"47","key":"10.1016\/j.vaccine.2019.10.074_b0135","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.1016\/j.vaccine.2011.09.007","article-title":"Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys","volume":"29","author":"Hu","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.074_b0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12985-017-0741-5","article-title":"A robust and cost-effective approach to sequence and analyze complete genomes of small RNA viruses","volume":"14","author":"Dimitrov","year":"2017","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.074_b0145","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","article-title":"MAFFT multiple sequence alignment software version 7: improvements in performance and usability","volume":"30","author":"Katoh","year":"2013","journal-title":"Mol Biol Evol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.10.074_b0150","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/gb-2010-11-8-r86","article-title":"Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences","volume":"11","author":"Goecks","year":"2010","journal-title":"Genome Biol"},{"issue":"6091","key":"10.1016\/j.vaccine.2019.10.074_b0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1217134","article-title":"Attenuated vaccines can recombine to form virulent field viruses","volume":"337","author":"Lee","year":"2012","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.vaccine.2019.10.074_b0160","doi-asserted-by":"crossref","first-page":"9303","DOI":"10.1128\/JVI.01231-08","article-title":"Not so fast on recombination analysis of Newcastle disease virus","volume":"82","author":"Afonso","year":"2008","journal-title":"J Virol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2019.10.074_b0165","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1099\/vir.0.020818-0","article-title":"How RNA viruses maintain their genome integrity","volume":"91","author":"Barr","year":"2010","journal-title":"J Gen Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.10.074_b0170","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1073\/pnas.90.9.4171","article-title":"Rates of spontaneous mutation among RNA viruses","volume":"90","author":"Drake","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.vaccine.2019.10.074_b0175","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S1286-4579(02)00008-4","article-title":"Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin","volume":"4","author":"Crotty","year":"2002","journal-title":"Microb Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2019.10.074_b0180","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1128\/jvi.67.8.4822-4830.1993","article-title":"The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA","volume":"67","author":"Calain","year":"1993","journal-title":"J Virol"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2019.10.074_b0185","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1099\/vir.0.80986-0","article-title":"Paramyxovirus mRNA editing, the \u201crule of six\u201d and error catastrophe: a hypothesis","volume":"86","author":"Kolakofsky","year":"2005","journal-title":"J Gen Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2019.10.074_b0190","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00559-17","article-title":"Genetic stability of parainfluenza virus 5-vectored human respiratory syncytial virus vaccine candidates after in vitro and in vivo passage","volume":"91","author":"Phan","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2019.10.074_b0195","first-page":"3","article-title":"Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease","volume":"372","author":"Collins","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.074_b0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1051\/vetres:200657","article-title":"Molecular biology of avian infectious laryngotracheitis virus","volume":"38","author":"Fuchs","year":"2007","journal-title":"Vet Res"},{"issue":"2 Suppl","key":"10.1016\/j.vaccine.2019.10.074_b0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1637\/10332-082612-Reg.1","article-title":"Identification and functional analysis of membrane proteins gD, gE, gI, and pUS9 of Infectious laryngotracheitis virus","volume":"57","author":"Pavlova","year":"2013","journal-title":"Avian Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931463X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1931463X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:39:46Z","timestamp":1759401586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1931463X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X1931463X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic stability of a Newcastle disease virus vectored infectious laryngotracheitis virus vaccine after serial passages in chicken embryos","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}